The Institute of Hygiene and Tropical Medicine (IHMT) in Lisbon reports on a new dengue vaccine that was made available in Portugal last week.
According to the director of the institute, Filomeno Fortes, the vaccine does not require prior contact with the virus and is effective against the disease and preventing hospitalizations up to four and a half years after vaccination.
The vaccine approved in December by INFARMED can be given to anyone (between ages of 4-60).
In addition, the vaccine protects against all types of dengue – is “80% effective at 12 months” and, in terms of preventing hospitalizations, it is 90.4% effective.
Fortes also adds that this new vaccine is “completely effective” with regard to dengue variant 2: “With the two doses, the probability of developing even mild symptoms is zero”.
Regarding the other serotypes (1, 3 and 4), those who are vaccinated can develop “a very mild disease”.
- Measles outbreak in Mauritania
- DRC: More than 70 cases of cholera notified in one week in Bukavu, South Kivu
- Kenya: Anthrax outbreak reported in Muranga County
- Cholera and diarrheal disease in South Africa
- Argentina dengue fever cases top 100,000 this season
- Five Exercises to Improve Wellness and Prevent Cancer During Women’s Health Week
- Pakistan reports 4th Mpox case, 1st in a female
- Dengue fever activity elevated nationwide in Sri Lanka
- Panama: Updated cases to date on dengue, malaria, hantavirus and more